EyeGene Inc. (KOSDAQ: 185490)
South Korea
· Delayed Price · Currency is KRW 2,900.00
+130.00 (4.69%)
Nov 15, 2024, 9:00 AM KST
EyeGene Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -12,335 | -21,106 | -25,953 | -34,569 | -14,863 | -8,740 | Upgrade
|
| Depreciation & Amortization | 2,503 | 2,137 | 1,291 | 1,070 | 853.25 | 703.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | 30.26 | 27.65 | -1.81 | 4.18 | 0.07 | 0.85 | Upgrade
|
| Asset Writedown & Restructuring Costs | 9.25 | 82.57 | - | - | - | 216.44 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,542 | 1,539 | 776.79 | -432.18 | -1,528 | -31.03 | Upgrade
|
| Loss (Gain) on Equity Investments | 194.4 | 168.96 | 23.21 | - | -17.09 | -217.47 | Upgrade
|
| Stock-Based Compensation | -1,503 | 1,873 | 3,866 | 1,363 | 243.84 | -7.81 | Upgrade
|
| Other Operating Activities | -4,524 | -4,539 | 3,170 | 1,564 | 4,673 | 715.33 | Upgrade
|
| Change in Accounts Receivable | 67.43 | 430.01 | -166.76 | 110.59 | 147.87 | -50.81 | Upgrade
|
| Change in Inventory | 10.06 | 442.8 | 276.39 | -69.91 | -393.36 | -104.64 | Upgrade
|
| Change in Accounts Payable | -383.58 | -393.15 | -1,030 | 364.01 | 598.25 | 340.93 | Upgrade
|
| Change in Other Net Operating Assets | -2,853 | -728.21 | -819.05 | 590.86 | 530.7 | -1,146 | Upgrade
|
| Operating Cash Flow | -17,243 | -20,065 | -18,568 | -30,004 | -9,754 | -8,321 | Upgrade
|
| Capital Expenditures | -931.54 | -1,385 | -767.86 | -2,378 | -2,034 | -990.94 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 9 | 5.36 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | -800 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -3,465 | -280.67 | -138.51 | -325.62 | -55.44 | -221.48 | Upgrade
|
| Investment in Securities | 2,873 | 7,329 | 18,950 | -54,498 | 6,540 | 12,284 | Upgrade
|
| Other Investing Activities | -1,450 | -0 | -0 | 524.7 | - | - | Upgrade
|
| Investing Cash Flow | -2,973 | 5,672 | 17,249 | -56,677 | 4,451 | 11,072 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 21,787 | - | Upgrade
|
| Long-Term Debt Repaid | - | -606.53 | -3,303 | -1,273 | -17,753 | -268.69 | Upgrade
|
| Net Debt Issued (Repaid) | -388.81 | -606.53 | -3,303 | -1,273 | 4,034 | -268.69 | Upgrade
|
| Issuance of Common Stock | 14,980 | 14,980 | - | 88,186 | 228.63 | 661.98 | Upgrade
|
| Other Financing Activities | 383.91 | 491.35 | 4,183 | -289.01 | -120.45 | 9.84 | Upgrade
|
| Financing Cash Flow | 18,772 | 17,853 | 879.97 | 86,624 | 4,142 | 403.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | -158.06 | -10.2 | -164.41 | -16.96 | 49.67 | - | Upgrade
|
| Net Cash Flow | -1,601 | 3,450 | -603.17 | -74.02 | -1,112 | 3,153 | Upgrade
|
| Free Cash Flow | -18,174 | -21,451 | -19,336 | -32,382 | -11,788 | -9,312 | Upgrade
|
| Free Cash Flow Margin | -639.76% | -686.33% | -365.27% | -998.79% | -350.48% | -219.35% | Upgrade
|
| Free Cash Flow Per Share | -744.27 | -990.99 | -901.68 | -1709.67 | -852.52 | -697.83 | Upgrade
|
| Cash Interest Paid | - | - | - | 8.51 | 51.8 | 27 | Upgrade
|
| Cash Income Tax Paid | - | 106.81 | 147.41 | -13.65 | -63.38 | 81.03 | Upgrade
|
| Levered Free Cash Flow | -13,656 | -13,590 | -15,529 | -20,460 | -10,497 | -8,126 | Upgrade
|
| Unlevered Free Cash Flow | -13,287 | -13,300 | -15,282 | -19,364 | -8,923 | -6,782 | Upgrade
|
| Change in Net Working Capital | -106.35 | -2,018 | 2,297 | -3,796 | -791.78 | 475.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.